ARTICLE | Top Story
DNA, XOMA delay Xanelim filing
October 4, 2001 7:00 AM UTC
Genentech (DNA) and partner Xoma (XOMA) said after market close on Thursday that the estimated BLA filing date for Xanelim, an anti-CD11a monoclonal antibody to treat moderate to severe psoriasis, wil...